AI Verdict
LFCR has stronger fundamentals based on our AI analysis.
LFCR vs LENZ Fundamental Comparison
| Metric | LFCR | LENZ |
|---|---|---|
| Revenue | $31.1M | $19.1M |
| Net Income | $-10.0M | $-82.1M |
| Net Margin | -32.1% | -430.3% |
| ROE | N/A | -28.9% |
| ROA | -4.2% | -26.8% |
| Current Ratio | 2.80x | 14.23x |
| Debt/Equity | N/A | 0.00x |
| EPS | $-0.29 | $-2.85 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LFCR vs LENZ: Frequently Asked Questions
Is LFCR or LENZ a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LFCR has stronger fundamentals. LFCR is rated STRONG SELL (85% confidence) while LENZ is rated STRONG SELL (80% confidence). This is not investment advice.
How does LFCR compare to LENZ fundamentally?
LIFECORE BIOMEDICAL, INC. DE has ROE of N/A vs LENZ Therapeutics, Inc.'s -28.9%. Net margins are -32.1% vs -430.3% respectively.
Which stock pays higher dividends, LFCR or LENZ?
LFCR has a dividend yield of N/A or no dividend while LENZ has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LFCR or LENZ for long term?
For long-term investing, consider that LFCR has STRONG SELL rating with 85% confidence, while LENZ has STRONG SELL rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LFCR vs LENZ?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LFCR vs LENZ, the AI consensus favors LFCR based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.